Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,188 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $246.83 | 10 | $0 (2023) |
| Novo Nordisk Inc | $215.40 | 32 | $0 (2024) |
| Nevro Corp. | $204.65 | 2 | $0 (2021) |
| ABBVIE INC. | $136.49 | 2 | $0 (2022) |
| SI-BONE, Inc. | $117.60 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $63.84 | 4 | $0 (2021) |
| Abbott Laboratories | $49.74 | 2 | $0 (2017) |
| Seqirus USA Inc | $27.66 | 1 | $0 (2023) |
| Flexion Therapeutics, Inc. | $20.54 | 1 | $0 (2019) |
| ORGANOGENESIS INC. | $17.38 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.34 | 1 | Novo Nordisk Inc ($15.34) |
| 2023 | $117.01 | 6 | Bayer Healthcare Pharmaceuticals Inc. ($65.86) |
| 2022 | $472.49 | 37 | Bayer HealthCare Pharmaceuticals Inc. ($180.97) |
| 2021 | $184.04 | 5 | Nevro Corp. ($112.30) |
| 2020 | $92.35 | 1 | Nevro Corp. ($92.35) |
| 2019 | $99.55 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($21.40) |
| 2018 | $144.42 | 3 | SI-BONE, Inc. ($117.60) |
| 2017 | $62.31 | 3 | Abbott Laboratories ($49.74) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Obesity | ||||||
| 09/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardio-renal | ||||||
| 08/10/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardio-renal | ||||||
| 07/13/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Cardio-renal | ||||||
| 06/19/2023 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological), Fluad Quadrivalent | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Vaccines | ||||||
| 02/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Cardio-renal | ||||||
| 02/19/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Obesity | ||||||
| 12/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: Cardio-renal | ||||||
| 12/07/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: INSOMNIA | ||||||
| 12/01/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 11/30/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $0.48 | General |
| Category: Diabetes | ||||||
| 11/17/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 11/03/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardio-renal | ||||||
| 10/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Cardio-renal | ||||||
| 09/15/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $108.89 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Diabetes | ||||||
| 09/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $0.32 | General |
| Category: Diabetes | ||||||
| 08/19/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Diabetes | ||||||
| 08/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $0.37 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: Diabetes | ||||||
| 06/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: Diabetes | ||||||
| 06/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $0.51 | General |
| Category: Diabetes | ||||||
| 05/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 73 | 525 | $45,376 | $14,409 |
| 2022 | 3 | 92 | 586 | $55,370 | $16,817 |
| 2021 | 3 | 80 | 489 | $49,275 | $15,876 |
| 2020 | 2 | 56 | 400 | $42,140 | $13,710 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 98941 | Chiropractic manipulative treatment, 3-4 spinal regions | Office | 2023 | 58 | 457 | $41,110 | $13,024 | 31.7% |
| 98940 | Chiropractic manipulative treatment, 1-2 spinal regions | Office | 2023 | 15 | 68 | $4,266 | $1,385 | 32.5% |
| 98941 | Chiropractic manipulative treatment, 3-4 spinal regions | Office | 2022 | 55 | 378 | $35,910 | $10,891 | 30.3% |
| 98942 | Chiropractic manipulative treatment, 5 spinal regions | Office | 2022 | 20 | 99 | $12,375 | $3,775 | 30.5% |
| 98940 | Chiropractic manipulative treatment, 1-2 spinal regions | Office | 2022 | 17 | 109 | $7,085 | $2,151 | 30.4% |
| 98941 | Chiropractic manipulative treatment, 3 to 4 spinal regions | Office | 2021 | 40 | 271 | $25,745 | $8,136 | 31.6% |
| 98942 | Chiropractic manipulative treatment, 5 spinal regions | Office | 2021 | 25 | 156 | $19,500 | $6,514 | 33.4% |
| 98940 | Chiropractic manipulative treatment, 1-2 spinal regions | Office | 2021 | 15 | 62 | $4,030 | $1,226 | 30.4% |
| 98941 | Chiropractic manipulative treatment, 3 to 4 spinal regions | Office | 2020 | 38 | 262 | $24,890 | $8,020 | 32.2% |
| 98942 | Chiropractic manipulative treatment, 5 spinal regions | Office | 2020 | 18 | 138 | $17,250 | $5,690 | 33.0% |
About Seth Smith, D.C
Seth Smith, D.C is a Chiropractor healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1023159373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Seth Smith, D.C has received a total of $1,188 in payments from pharmaceutical and medical device companies, with $15.34 received in 2024. These payments were reported across 62 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,188).
As a Medicare-enrolled provider, Smith has provided services to 301 Medicare beneficiaries, totaling 2,000 services with total Medicare billing of $60,812. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Chiropractor
- Location Palm Beach Gardens, FL
- Active Since 02/09/2007
- Last Updated 08/27/2025
- Taxonomy Code 111N00000X
- Entity Type Individual
- NPI Number 1023159373
Products in Payments
- Kerendia (Drug) $246.83
- UBRELVY (Drug) $136.49
- Rybelsus (Drug) $125.57
- iFuse Implant (Device) $117.60
- Omnia (Device) $112.30
- Senza Spinal Cord Stimulation System (Device) $92.35
- DRG IPGs (Device) $49.74
- RYBELSUS (Drug) $38.74
- XIFAXAN (Drug) $37.02
- FLUCELVAX QUADRIVALENT (Biological) $27.66
- XIFAXANIBSD (Drug) $26.82
- Saxenda (Drug) $23.49
- Zilretta (Drug) $20.54
- Puraply (Medical Supply) $17.38
- QUVIVIQ (Drug) $17.20
- XARELTO (Drug) $16.59
- Wegovy (Drug) $15.34
- SPECTRA WAVEWRITER (Device) $15.29
- Supartz (Device) $12.57
- Ozempic (Drug) $12.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Chiropractor Doctors in Palm Beach Gardens
Brent Sanders, Dc, Pa-C, DC, PA-C
Chiropractor — Payments: $744.39
Dr. Michael Bahr, D.c, D.C
Chiropractor — Payments: $364.84
Christopher Horne, D.c, D.C
Chiropractor — Payments: $185.18
Dr. Alex Wasserman, Dc, DC
Chiropractor — Payments: $150.00
Dr. Ibrar Ahmad
Chiropractor — Payments: $127.16
Paige Rembos
Chiropractor — Payments: $106.87